Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01804296 · ClinicalTrials.gov registry record · NA
rTMS for Depressed Teens: A Sham-Controlled Trial, Part 2
A NA study, sponsored by Paul E. Croarkin.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT01804296 is a NA study that was terminated before completion, run by Paul E. Croarkin. The registered enrollment target is 4 participants.
The verdict
NCT01804296, a NA study, was terminated before completion, sponsored by Paul E. Croarkin.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
This research proposal aims to better understand the neurobiology of depression in adolescents and how repetitive transcranial magnetic stimulation (rTMS) may therapeutically impact brain function and mood. This investigation also proposes the first study to examine the efficacy of rTMS maintenance therapy in adolescents who have met clinical criteria following acute rTMS treatment. The magnetic resonance (MR) spectroscopy pattern of rTMS response will be analyzed according to previously established protocols.
Interventions
- DEVICE Repetitive transcranial magnetic stimulation (rTMS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2013-03 |
| Est. Completion | 2015-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01804296
The ClinicalTrials.gov registry entry for NCT01804296 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Paul E. Croarkin, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Repetitive transcranial magnetic stimulation (rTMS) is the first listed.
NCT01804296 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01804296 about?
NCT01804296 is a clinical study titled "rTMS for Depressed Teens: A Sham-Controlled Trial, Part 2". This research proposal aims to better understand the neurobiology of depression in adolescents and how repetitive transcranial magnetic stimulation (rTMS) may therapeutically impact brain function and mood. This investigation also proposes the first study to examine the efficacy of rTMS maintenance ...
What is the current status of trial NCT01804296?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2013-03. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01804296?
The interventions under investigation include: Repetitive transcranial magnetic stimulation (rTMS) (DEVICE).
Who is sponsoring clinical trial NCT01804296?
This trial is sponsored by Paul E. Croarkin, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.